Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEET

v3.3.0.814
CONSOLIDATED BALANCE SHEET - USD ($)
Aug. 31, 2015
Aug. 31, 2014
Current    
Cash and cash equivalents $ 260,075 $ 703,030
Accounts receivable 31,382 97,003
Inventory 167,986 0
Assets Held For Sale 0 1,400,000
Prepaid expenses and deposit 215,290 367,441
Total Current Assets 674,733 2,567,474
Patent 36,989 0
Medical Marijuana Investments 0 67,662
Total Noncurrent Assets 36,989 67,662
TOTAL ASSETS 711,722 2,635,136
Current    
Accounts payable and accrued liabilities 33,073 93,553
Loan payable 0 776,936
Share Subscriptions Receivable 0 45,780
Due to a related party 22,052 1,769
Total Current Liabilities 55,125 918,038
TOTAL LIABILITIES 55,125 918,038
STOCKHOLDERS' EQUITY    
Share Capital Authorized: 200,000,000 common voting shares with a par value of $0.001 per share Issued and outstanding: 39,852,984 common shares at August 31, 2015 and 34,249,690 common shares at August 31, 2014 39,852 34,249
Additional paid-in capital 10,818,446 10,033,438
Shares to be returned 0 (35,200)
Deficit (10,085,889) (8,315,389)
Equity attributable to shareholders of the Company 772,409 1,717,098
Non-Controlling Interest (115,812) 0
Total Stockholders' Equity 656,597 1,717,098
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 711,722 $ 2,635,136